Log In
BCIQ
Print this Print this
 

Naitgam (Human platelet antigen-1a (HPA-1a) immunoglobulin)

  Manage Alerts
Collapse Summary General Information
Company Prophylix Pharma A/S
DescriptionIgG antibodies against HPA-1a immunoglobulin
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationThrombocytopenia
Indication DetailsPrevent fetal and neonatal alloimmune thrombocytopenia (NAIT) due to HPA-1a incompatibility
Regulatory Designation EU - Orphan Drug (Prevent fetal and neonatal alloimmune thrombocytopenia (NAIT) due to HPA-1a incompatibility)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today